Latest Continuous Disclosure News

Regener8 Resources has addressed a sharp doubling in its share price, attributing the surge to growing market interest in its North Achilles project amid soaring silver prices and nearby discoveries.

Superior Resources Limited clarifies recent share price jump, attributing it to soaring gold prices and imminent resource updates, while confirming no undisclosed information.

VHM Limited has clarified that a non-binding US$200 million letter of interest from the US Export-Import Bank for its Goschen project is not material to its share price, confirming full compliance with ASX disclosure rules despite recent market speculation.

Findi Limited has responded to ASX inquiries about unusual stock price and volume movements, denying any undisclosed information and announcing legal action against a former subsidiary executive for misleading social media posts.

Nordic Resources Ltd attributes its recent share price and volume spike to a successful investor roadshow and capital raising tied to its new Finland gold projects, while confirming full ASX compliance.

Discovery Alaska Limited has detailed its exploration expenditures and strategic pivot from Alaskan projects to new US acquisitions, affirming its financial health and operational sufficiency to maintain its ASX listing.

Wellard Limited has formally requested to delist from the ASX following the sale of its final revenue-generating vessel, aiming to reduce costs and return excess cash to shareholders. The move awaits shareholder approval at the upcoming AGM.

Mount Burgess Mining (MTB) has responded to an ASX price query, confirming no undisclosed material information beyond previously announced gold project acquisitions and debt conversion plans ahead of its upcoming EGM.

Hastings Technology Metals has responded to an ASX price query, denying any undisclosed information behind its recent share price and volume spike, citing recent joint venture and asset sale announcements as likely drivers.

Kula Gold Limited has addressed recent share price and volume spikes, confirming no undisclosed information while highlighting exploration progress and market factors driving investor interest.

Adamantem Capital Management has completed its due diligence on Apiam Animal Health and extended its exclusivity period to negotiate a potential $0.87 per share acquisition. The deal remains subject to approvals and binding agreements.

Battery Age Minerals has addressed a sharp rise in its share price and trading volume, attributing the activity to recent research coverage and ongoing exploration updates rather than undisclosed information.